%0 Journal Article
%T 冠心病发病机制及中西医治疗思路与用药
The Pathogenesis of Coronary Heart Disease and the Treatment Ideas and Medication of Traditional Chinese and Western Medicine
%A 王琳
%J Advances in Clinical Medicine
%P 109-114
%@ 2161-8720
%D 2025
%I Hans Publishing
%R 10.12677/acm.2025.151017
%X 冠心病的发病原因有很多，西医解释为脂质代谢异常、心肌线粒体功能障碍、血液粘度增大、平滑肌增生。中医早在千百年前已经将该类疾病命名为“胸痹”，将病机概括为阳微阴弦、气虚血瘀、气滞血瘀等。西医与中医对冠心病的认识虽看似有很大不同，但治疗思路本质上看是如出一辙的，均从改善血液状态、改善心肌功能、降低血液脂蛋白等方面着手。对中医经典方中常用的治疗冠心病的药物进行药理分析后，发现其作用原理与西药相似。
There are many causes of coronary heart disease. Western medicine interprets it as abnormal lipid metabolism, myocardial mitochondrial dysfunction, increased blood viscosity, and smooth muscle hyperplasia. Traditional Chinese medicine has named this kind of disease “thoracic paralysis” as early as thousands of years ago, and the pathogenesis is summarized as weak pulse at yang and stringy pulse at yin, qi deficiency to blood stasis, qi stagnation to blood stasis, etc. Although the understanding of coronary heart disease in Western medicine and traditional Chinese medicine seems to be very different, the treatment ideas are essentially the same, both starting from improving blood status, improving myocardial function, and reducing blood lipoprotein. After pharmacological analysis, it was found that the principle of action of the commonly used drugs for the treatment of coronary heart disease in the classic prescription of traditional Chinese medicine was similar to that of Western medicine.
%K 血液粘度，
%K 阳微阴弦，
%K 线粒体，
%K 同型半胱氨酸，
%K TCSK9抑制剂
Blood Viscosity
%K Yang Microyin Chine
%K Mitochondria
%K Homocysteine
%K TCSK9 Inhibitor
%U http://www.hanspub.org/journal/PaperInformation.aspx?PaperID=104666